DAVIPHARM

Davipharm is one of the leading domestic manufacturers of high-quality generic medicines. Established in 2004, certified in 2006 with WHO-GMP, in 2014 Davipharm reached first 100 registered products and started exporting its medicinal products to the Philippines and Cambodia. In 2017, Adamed Pharma S.A., a Polish pharmaceutical and biotechnology company, acquired the controlling stake in Davipharm. It has been the biggest direct private Polish investment in Vietnam by now. Today, Davipharm is the fifth biggest local pharmaceutical company on the prescription drug market. With over $10 million invested by Adamed by the end of 2020 in Davipharm’s production plant in the southern province of Binh Duong, know-how and technology transfer, upgrade of production standards to implement the EU-GMP and export development, Davipharm will continue to strengthen its market position.